The latest price target for Procter & Gamble (NYSE:PG) was reported by UBS on April 27, 2026. The analyst firm set a price target for $172.00 expecting PG to rise to within 12 months (a possible 17.55% upside). 37 analyst firms have reported ratings in the last year.

The latest analyst rating for Procter & Gamble (NYSE:PG) was provided by UBS, and Procter & Gamble maintained their buy rating.

The last upgrade for Procter & Gamble Co happened on January 23, 2026 when JP Morgan raised their price target to $165. JP Morgan previously had a neutral for Procter & Gamble Co.

The last downgrade for Procter & Gamble Co happened on January 27, 2026 when TD Cowen changed their price target from $150 to $156 for Procter & Gamble Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Procter & Gamble, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Procter & Gamble was filed on April 27, 2026 so you should expect the next rating to be made available sometime around April 27, 2027.

While ratings are subjective and will change, the latest Procter & Gamble (PG) rating was a maintained with a price target of $166.00 to $172.00. The current price Procter & Gamble (PG) is trading at is $146.32, which is out of the analyst’s predicted range.